These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23803585)

  • 21. Differential regulation by anti-tumor-promoting 12-deoxyphorbol-13-phenylacetate reveals distinct roles of the classical and novel protein kinase C isozymes in biological responses of primary mouse keratinocytes.
    Szallasi Z; Kosa K; Smith CB; Dlugosz AA; Williams EK; Yuspa SH; Blumberg PM
    Mol Pharmacol; 1995 Feb; 47(2):258-65. PubMed ID: 7870033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of 7,8-disubstituted benzolactam-V8 and its binding to protein kinase C.
    Ma D; Zhang T; Wang G; Kozikowski AP; Lewin NE; Blumberg PM
    Bioorg Med Chem Lett; 2001 Jan; 11(2):99-101. PubMed ID: 11206480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of indirubin-N'-glycosides and their anti-proliferative activity against human cancer cell lines.
    Libnow S; Methling K; Hein M; Michalik D; Harms M; Wende K; Flemming A; Köckerling M; Reinke H; Bednarski PJ; Lalk M; Langer P
    Bioorg Med Chem; 2008 May; 16(10):5570-83. PubMed ID: 18434163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes.
    Kazanietz MG; Areces LB; Bahador A; Mischak H; Goodnight J; Mushinski JF; Blumberg PM
    Mol Pharmacol; 1993 Aug; 44(2):298-307. PubMed ID: 8355667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives.
    Fu W; Wang J; Yu L; Zhao L; Lu N; You Q; Guo Q; Li Z
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1118-21. PubMed ID: 22196122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
    Alafeefy AM; Ashour AE
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines.
    Burlison JA; Avila C; Vielhauer G; Lubbers DJ; Holzbeierlein J; Blagg BS
    J Org Chem; 2008 Mar; 73(6):2130-7. PubMed ID: 18293999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-preventive selenocompounds induce a specific redox modification of cysteine-rich regions in Ca(2+)-dependent isoenzymes of protein kinase C.
    Gopalakrishna R; Gundimeda U; Chen ZH
    Arch Biochem Biophys; 1997 Dec; 348(1):25-36. PubMed ID: 9390171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosquaramides as kinase inhibitors with anticancer activity.
    Villalonga P; Fernández de Mattos S; Ramis G; Obrador-Hevia A; Sampedro A; Rotger C; Costa A
    ChemMedChem; 2012 Aug; 7(8):1472-80. PubMed ID: 22777958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uniform potent activity of the antiproliferative metal chelate trans-bis(resorcylaldoximato)copper(II) against a large panel of human tumor cell lines in vitro.
    Elo H
    Chemotherapy; 2004 Nov; 50(5):229-33. PubMed ID: 15528888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-delta with Src family kinases in the RBL-2H3 mast cell line: regulation of Src family kinase activity by protein kinase C-delta.
    Song JS; Swann PG; Szallasi Z; Blank U; Blumberg PM; Rivera J
    Oncogene; 1998 Jul; 16(26):3357-68. PubMed ID: 9692543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/pi interaction.
    Sugimoto T; Itagaki K; Irie K
    Bioorg Med Chem; 2008 Jan; 16(2):650-7. PubMed ID: 17977729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Synthesis and anti-tumor activity of paeonol and its derivatives].
    Wang XJ; Liu JL; Wang JK
    Yao Xue Xue Bao; 2012 Jan; 47(1):72-6. PubMed ID: 22493808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structures of the PKC-iota kinase domain in its ATP-bound and apo forms reveal defined structures of residues 533-551 in the C-terminal tail and their roles in ATP binding.
    Takimura T; Kamata K; Fukasawa K; Ohsawa H; Komatani H; Yoshizumi T; Takahashi I; Kotani H; Iwasawa Y
    Acta Crystallogr D Biol Crystallogr; 2010 May; 66(Pt 5):577-83. PubMed ID: 20445233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Quantitative Structure-Activity Relationship (QSAR) and ADMET prediction studies as screening methods for design of benzyl urea derivatives for anti-cancer activity.
    Lokwani D; Bhandari S; Pujari R; Shastri P; Shelke G; Pawar V
    J Enzyme Inhib Med Chem; 2011 Jun; 26(3):319-31. PubMed ID: 20846089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents.
    Abuhaie CM; Bîcu E; Rigo B; Gautret P; Belei D; Farce A; Dubois J; Ghinet A
    Bioorg Med Chem Lett; 2013 Jan; 23(1):147-52. PubMed ID: 23200248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex vivo assays to evaluate the role of protein kinase C in tumor cells of patients with breast cancer.
    Schöndorf T; Becker M; Kolhagen H; Kurbacher CM; Göhring UJ
    Anticancer Res; 2000; 20(6D):5073-6. PubMed ID: 11326671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding mode prediction of aplysiatoxin, a potent agonist of protein kinase C, through molecular simulation and structure-activity study on simplified analogs of the receptor-recognition domain.
    Ashida Y; Yanagita RC; Takahashi C; Kawanami Y; Irie K
    Bioorg Med Chem; 2016 Sep; 24(18):4218-4227. PubMed ID: 27436807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples.
    Sharif TR; Sharif M
    Int J Oncol; 1999 Aug; 15(2):237-43. PubMed ID: 10402232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.